BackNektar Therapeutics Overview

Nektar Therapeutics Accounts Payable

Latest accounts payable for NKTR: $10M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$10.03M

Peer average / median

Loading

Nektar Therapeutics Accounts Payable History

Loading

Nektar Therapeutics vs. peers: Accounts Payable Comparison

Loading

Nektar Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nektar Therapeutics (NKTR) FAQ

Nektar Therapeutics (NKTR) currently reports a accounts payable of $10M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Nektar Therapeutics's accounts payable history and peer comparisons.

Nektar Therapeutics's accounts payable changed from $0 to $10M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nektar Therapeutics reported $10M in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nektar Therapeutics, and consider following NKTR for alerts when major investors trade the stock.

Nektar Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NKTR with unrelated industries.